If you have been diagnosed with uterine sarcoma and you have been referred to Fred Hutch Cancer Center for treatment, here are some of the treatment choices you may be offered. Remember, each woman’s ...

A randomized phase 2 maintenance strategy with cabozantinib 60 mg daily for up to 2 years failed to improve 4-month PFS versus placebo in high-grade uterine sarcomas. Median PFS was identical at 3.7 ...

Uterine sarcoma - a potentially aggressive type of cancer that forms in tissues in the uterus - was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study by ...

Leiomyosarcoma, the most frequent pure uterine sarcoma, is an aggressive tumor with a tendency toward early relapse. Survival for patients with recurrent disease is poor. In contrast, endometrial ...

"Uterine sarcomas have generally been underexplored due to their rareness; nevertheless, they behave aggressively and are difficult to treat, resulting in a high clinical need," said Amant.

GDF15 and OPN show promise in differentiating uterine sarcoma from leiomyoma, outperforming traditional markers like LDH and CA125. GDF15 serves as an independent prognostic factor for ...

Uterine sarcoma -- a potentially aggressive type of cancer that forms in tissues in the uterus -- was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study ...

Uterine fibroids are benign tumors that are not likely to lead to malignant cancer. Approximately 70% of women have these benign tumors by the time they reach the age of 50 but these women are not ...

Uterine leiomyosarcoma is difficult to distinguish from fibroids, complicating diagnosis and often requiring surgical confirmation. African American women have a doubled risk of developing uterine ...

Leiomyosarcoma, the most frequent pure uterine sarcoma, is an aggressive tumor with a tendency toward early relapse. Survival for patients with recurrent disease is poor. In contrast, endometrial ...

Symptoms that mimic fibroids make diagnosing uterine sarcoma a rare and confounding cancer. In 2014, Dionne Shepperson, then 40 and pregnant, began feeling weak and faint. Because she had in the past ...